EGFR and non-small cell lung carcinoma: The epidermal growth factor receptor (EGFR) represents an important signalling pathway that regulates tumorigenesis and cell survival and is frequently overexpressed in the development and progression of non-small cell lung cancer (NSCLC) [7, 8].